Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Merion

Showing results (121-130 of 135) with videos related to

Pageof 14
Sort By:
Gut|October 1, 1992
Recurrence of hepatitis B and delta hepatitis after orthotopic liver transplantationM R Lucey, D M Graham, P Martin, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 16, 2011
The economic implications of broader sharing of liver allograftsD A Axelrod, A Gheorghian, M A Schnitzler, et al.
Hepatology (Baltimore, Md.)|September 11, 1992
Biochemical and histopathological correlation in liver transplant: the first 180 daysK S Henley, M R Lucey, H D Appelman, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 6, 2009
Incidence and severity of acute cellular rejection in recipients undergoing adult living donor or deceased donor liver transplantationA Shaked, R M Ghobrial, R M Merion, et al.
Antimicrobial Agents and Chemotherapy|September 19, 2000
Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipientsM D Pescovitz, J Rabkin, R M Merion, et al.
Hepatology (Baltimore, Md.)|February 1, 1995
A double-blind, randomized, placebo-controlled trial of prostaglandin E1 in liver transplantationK S Henley, M R Lucey, D P Normolle, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 14, 2007
Risk factors for urinary complications after renal transplantationM J Englesbe, D A Dubay, B W Gillespie, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 10, 2013
Health-related quality of life in kidney donors from the last five decades: results from the RELIVE studyC R Gross, E E Messersmith, B A Hong, et al.
Transplantation Proceedings|September 15, 2012
Predictors of liver donation without kidney recovery in a cohort of expanded criteria donors: identifying opportunities to improve expanded criteria donor kidney utilizationS L White, A B Leichtman, K O'Connor, et al.
Clinical Transplantation|June 1, 2000
Intravenous mycophenolate mofetil: safety, tolerability, and pharmacokineticsM D Pescovitz, D Conti, J Dunn, et al.
Pageof 14

Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
Gut|October 1, 1992
Recurrence of hepatitis B and delta hepatitis after orthotopic liver transplantationM R Lucey, D M Graham, P Martin, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 16, 2011
The economic implications of broader sharing of liver allograftsD A Axelrod, A Gheorghian, M A Schnitzler, et al.
Hepatology (Baltimore, Md.)|September 11, 1992
Biochemical and histopathological correlation in liver transplant: the first 180 daysK S Henley, M R Lucey, H D Appelman, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 6, 2009
Incidence and severity of acute cellular rejection in recipients undergoing adult living donor or deceased donor liver transplantationA Shaked, R M Ghobrial, R M Merion, et al.
Antimicrobial Agents and Chemotherapy|September 19, 2000
Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipientsM D Pescovitz, J Rabkin, R M Merion, et al.
Hepatology (Baltimore, Md.)|February 1, 1995
A double-blind, randomized, placebo-controlled trial of prostaglandin E1 in liver transplantationK S Henley, M R Lucey, D P Normolle, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 14, 2007
Risk factors for urinary complications after renal transplantationM J Englesbe, D A Dubay, B W Gillespie, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 10, 2013
Health-related quality of life in kidney donors from the last five decades: results from the RELIVE studyC R Gross, E E Messersmith, B A Hong, et al.
Transplantation Proceedings|September 15, 2012
Predictors of liver donation without kidney recovery in a cohort of expanded criteria donors: identifying opportunities to improve expanded criteria donor kidney utilizationS L White, A B Leichtman, K O'Connor, et al.
Clinical Transplantation|June 1, 2000
Intravenous mycophenolate mofetil: safety, tolerability, and pharmacokineticsM D Pescovitz, D Conti, J Dunn, et al.
Pageof 14